• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX 16.7% 0.5¢

INVION LIMITED

Invion Limited is an Australia-based life sciences company. The Company is engaged in the... Invion Limited is an Australia-based life sciences company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is engaged in the clinical development of a PhotoDynamic Therapy (PDT) for cancer. Its photosensitizer (the agent used in PDT) is called IVX-PDT and is based on Photosoft Technology. Its PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. It produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. It is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IVX 30/04/24 1 383
30/04/24 Last post  Rtj1953 Comments Created with Sketch.  1  Views Created with Sketch.  383 
IVX
Approval and Commencement of clinical Trials Australian Government Cancer.
10/04/24 2 1.3K
10/04/24 Last post  cashflowmonday Comments Created with Sketch.  2  Views Created with Sketch.  1.3K 
IVX 29/03/24 18 6.9K
Metals & Mining SECTOR NEWS

8th Regional Uranium Anomaly Confirmed at Saraya Project - Potential for new discoveries still exists!

HAR
03 May 2024
HARANGA RESOURCES LIMITED.
29/03/24 Last post  simonaw Comments Created with Sketch.  18  Views Created with Sketch.  6.9K 
IVX 05/03/24 0 364
05/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  364 
IVX
ACHIEVING ~80% TUMOUR CONTROL IN PRECLINICAL STUDIES
05/03/24 0 225
05/03/24 Last post  cashngrab Comments Created with Sketch.  0  Views Created with Sketch.  225 
IVX 28/02/24 0 289
28/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  289 
IVX 24/02/24 2 1.0K
24/02/24 Last post  Rtj1953 Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
IVX
ASX:IVX - Latest research update on Invion from Pitt Street
24/02/24 2 1.0K
24/02/24 Last post  Chuckm61 Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 

See All Discussions arrow Created with Sketch.

Timeline

Activities Report and Appendix 4C
30 Apr 13:12
 
Presentation at East-West Summit in Singapore
05 Mar 08:37
 
INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
04 Mar 16:06
 
Appendix 4D and Half Year Financial Report
28 Feb 09:29
 
Agreement with Dr.inB to develop Photosoft treatment for HPV
23 Feb 09:04
 
Activities Report and Appendix 4C
30 Jan 08:55
 
View More arrow Created with Sketch.
(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $32.12M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $15.28K 3.056M

Buyers (Bids)

No. Vol. Price($)
4 880901 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 7143246 13
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
0.6¢
  Change
-0.001 ( 10.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 971625
Last updated 14.46pm 03/05/2024 ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.